Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Perrigo Company PLC (NYSE:PRGO)

84.47
Delayed Data
As of Feb 17
 +1.35 / +1.62%
Today’s Change
71.84
Today|||52-Week Range
146.16
+1.49%
Year-to-Date

Today’s Trading

Previous close83.12
Today’s open83.09
Day’s range82.54 - 84.64
Volume1,282,001
Average volume (3 months)1,747,495
Market cap$12.1B
Dividend yield0.69%
Data as of 4:01pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)-95.67%
Earnings growth (this year)--
Earnings growth (next 5 years)+7.40%
Revenue growth (last year)+36.36%
P/E ratio17.8
Price/Sales3.82
Price/Book1.20

Competitors

 Today’s
change
Today’s
% change
TSROTESARO Inc+7.80+4.27%
SGENSeattle Genetics Inc+0.20+0.31%
BMRNBiomarin Pharmaceuti...-0.66-0.73%
ALKSAlkermes Plc-0.98-1.76%
Data as of 4:00pm ET, 02/17/2017

Financials

Next reporting dateFebruary 23, 2017
EPS forecast (this quarter)$1.62
Annual revenue (last year)$5.5B
Annual profit (last year)$11.2M
Net profit margin0.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
John T. Hendrickson
Executive VP, Chief Financial &
Accounting Officer
Judy L. Brown
Corporate headquarters
Dublin, Dublin

Forecasts


Search for Jobs